Fennec Pharmaceuticals Directors Elected Confidently
Company Announcements

Fennec Pharmaceuticals Directors Elected Confidently

Fennec Pharmaceuticals (TSE:FRX) has released an update.

Fennec Pharmaceuticals Inc. has successfully elected its director nominees at the Annual General Meeting of Shareholders, with overwhelming support for each candidate and almost unanimous approval for the appointment of Haskell & White LLP as auditors. Shareholders showed strong endorsement for the executive compensation plan, with a high approval rating. The meeting signified shareholder confidence in the company’s leadership and direction.

For further insights into TSE:FRX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskFennec Pharmaceuticals Reports Strong Q3 Results
TipRanks Auto-Generated NewsdeskFennec Pharmaceuticals Reports Q3 2024 Financial Results
TheFlyFennec price target lowered to $15 from $22 at Maxim
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App